/ bladder cancer
Amid Biotech Pitfalls, this Stock Has Outperformed NVDA in the Last 3 Months
In the last three months, this biotech stock outperformed Nvidia (NVDA) by over 3x.
May 13, 2024In the last three months, this biotech stock outperformed Nvidia (NVDA) by over 3x.
May 13, 2024